Panagiotis K. Petrou

17-19, Klimentos Street
Nicosia, 1061, Cyprus

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Cost-neutral adoption of anti-VEGF therapies in neovascular age-related macular degeneration.

Cost-neutral adoption of anti-VEGF therapies in neovascular age-related macular degeneration.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: August 21, 2026

Cost per event avoided: adopt or avoid?

Cost per event avoided: adopt or avoid?

Journal: Journal of medical economics

Published: March 16, 2026

Therapeutic Drug Monitoring guided vedolizumab treatment in ulcerative colitis in Cyprus: a cost-effectiveness analysis.

Therapeutic Drug Monitoring guided vedolizumab treatment in ulcerative colitis in Cyprus: a cost-effectiveness analysis.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: February 02, 2026

One man's waste is another man's treasure: the case of wastewater-based Respiratory Syncytial Virus surveillance's efficiency.

One man's waste is another man's treasure: the case of wastewater-based Respiratory Syncytial Virus surveillance's efficiency.

Journal: Journal of medical economics

Published: July 25, 2025

National outpatient antibiotic prescriptions in Cyprus, 2020-2022.

National outpatient antibiotic prescriptions in Cyprus, 2020-2022.

Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE

Published: February 20, 2025

Evaluating Greek pharmacists' attitudes and barriers regarding medicines adherence.

Evaluating Greek pharmacists' attitudes and barriers regarding medicines adherence.

Journal: Journal of pharmaceutical policy and practice

Published: May 27, 2024

The efficiency of TAVI in intermediate and low-risk Japanese patients.

The efficiency of TAVI in intermediate and low-risk Japanese patients.

Journal: Journal of medical economics

Published: May 25, 2024

Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus.

Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus.

Journal: PharmacoEconomics - open

Published: March 03, 2024

Eliciting health state utilities in Japanese diabetic and obese patients through the time trade-off method. Does the conjecture fat and happy stand true?

Eliciting health state utilities in Japanese diabetic and obese patients through the time trade-off method. Does the conjecture fat and happy stand true?

Journal: Journal of medical economics

Published: February 12, 2024

Cost-effectiveness of Left Atrial Appendage Closure with WATCHMAN device for non-valvular atrial fibrillation patients in Japan. Are the policy implications big in Japan?

Cost-effectiveness of Left Atrial Appendage Closure with WATCHMAN device for non-valvular atrial fibrillation patients in Japan. Are the policy implications big in Japan?

Journal: Journal of medical economics

Published: October 05, 2023

Implementing a Managed Entry Agreement Framework in Cyprus.

Implementing a Managed Entry Agreement Framework in Cyprus.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: July 23, 2023

CAR-T therapy for multiple myeloma in China. Does it make sense financially?

CAR-T therapy for multiple myeloma in China. Does it make sense financially?

Journal: Journal of medical economics

Published: June 12, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026